The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for HCP Investments
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
HCP Investments, a Mauritius-based non-promoter shareholder, has sold 6,503,423 equity shares (7.5% of total paid-up capital) of Ind-Swift Laboratories Limited through open market transactions. The sale was executed between 13 April and 16 April 2026. Prior to the sale, HCP held 7,500,000 shares (8.649%). After the sale, their holding reduced significantly to 996,577 shares (1.149%). The acquirer is explicitly stated as NOT belonging to the Promoter/Promoter group.
A substantial reduction in a non-promoter shareholder's stake from 8.65% to 1.15%, indicating exit or significant reduction in holding by this investor. This does not directly impact promoter holding but may signal reduced institutional confidence or profit-taking.